The pill, parity, and rheumatoid arthritis.

We report on a case-control study investigating the relationship of oral contraceptive pill (OCP) use and parity to the development of rheumatoid arthritis (RA). Women with RA were compared with 2 separate control groups, women with osteoarthritis (OA) and women randomly selected from a population-based electoral register. Nulliparity was found to be a risk factor for the development of RA, with age-adjusted odds ratios of 1.82 (95% confidence interval [CI] 1.09-3.03) versus the OA control group and 1.83 (95% CI 1.03-3.06) versus the population control group. Use of OCPs before the age of 35 was negatively associated with RA (odds ratio 0.56, 95% CI 0.29-1.12 versus the OA control group; odds ratio 0.6, 95% CI 0.30-1.17 versus the population control group). Some evidence of a duration-response effect was seen, although the numbers were small. The 2 variables were also multiplicative, with nulliparous non-OCP users having a 4-fold risk of RA compared with parous OCP users. These findings suggest that pregnancy and OCP use have a "protective effect" on the development of RA, although the mechanism remains unclear.

[1]  A. Silman,et al.  Is poor pregnancy outcome a risk factor in rheumatoid arthritis? , 1990, Annals of the rheumatic diseases.

[2]  T. Spector,et al.  The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis. , 1989, British journal of rheumatology.

[3]  M. Pike,et al.  The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy. , 1989, Contraception.

[4]  V. Beral,et al.  Adverse reproductive outcomes in women who subsequently develop rheumatoid arthritis. , 1988, Annals of the rheumatic diseases.

[5]  D. Stanworth.  A possible immunochemical explanation for pregnancy associated remissions in rheumatoid arthritis? , 1988, Annals of the rheumatic diseases.

[6]  M. Pike,et al.  Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. , 1987, British Journal of Cancer.

[7]  J. Bijlsma,et al.  Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. , 1987, Annals of the rheumatic diseases.

[8]  D. Kennedy,et al.  Oral contraceptives in the United States: trends in content and potency. , 1987, International journal of epidemiology.

[9]  M. Vessey,et al.  Oral contraceptives, cigarette smoking and other factors in relation to arthritis. , 1987, Contraception.

[10]  A. Ahlbom,et al.  Hospital versus population referents in two case-referent studies. , 1987, Scandinavian journal of work, environment & health.

[11]  A. Silman,et al.  Oral contraceptives and rheumatoid arthritis. Bias in observational studies of cause-effect relationships. , 1987, Journal of chronic diseases.

[12]  A. Cartwright.  Who responds to postal questionnaires? , 1986, Journal of epidemiology and community health.

[13]  A. Cats,et al.  Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. , 1986, JAMA.

[14]  J. Esdaile,et al.  Observational studies of cause-effect relationships: an analysis of methodologic problems as illustrated by the conflicting data for the role of oral contraceptives in the etiology of rheumatoid arthritis. , 1986, Journal of Chronic Diseases.

[15]  S. Ansar Ahmed,et al.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. , 1985, The American journal of pathology.

[16]  J. Annegers,et al.  Do oral contraceptives prevent rheumatoid arthritis? , 1985, JAMA.

[17]  C. Dinarello,et al.  Increased plasma interleukin-1 activity in women after ovulation. , 1985, Science.

[18]  P. Allebeck,et al.  Do oral contraceptives reduce the incidence of rheumatoid arthritis? A pilot study using the Stockholm County medical information system. , 1984, Scandinavian journal of rheumatology.

[19]  P. Drury,et al.  Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis. , 1983, Annals of the rheumatic diseases.

[20]  A. Linos,et al.  CASE-CONTROL STUDY OF RHEUMATOID ARTHRITIS AND PRIOR USE OF ORAL CONTRACEPTIVES , 1983, The Lancet.

[21]  G. Panayi,et al.  Disease activity and pregnancy associated alpha 2-glycoprotein in rheumatoid arthritis during pregnancy. , 1983, British medical journal.

[22]  P M Layde,et al.  Agreement between women's histories of oral contraceptive use and physician records. , 1983, International journal of epidemiology.

[23]  A. Cats,et al.  ORAL CONTRACEPTIVES AND RHEUMATOID ARTHRITIS: FURTHER EVIDENCE FOR A PREVENTIVE EFFECT , 1982, The Lancet.

[24]  A. Feinstein,et al.  Alternative data sources and discrepant results in case-control studies of estrogens and endometrial cancer. , 1980, American Journal of Epidemiology.

[25]  A. Linos,et al.  The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. , 1980, American journal of epidemiology.

[26]  P. Stolley,et al.  Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. , 1978, American journal of epidemiology.

[27]  J. S. Lawrence,et al.  Rheumatism in populations , 1977 .

[28]  M. Vessey,et al.  Accuracy of recall of histories of oral contraceptive use , 1974, British journal of preventive & social medicine.

[29]  A. Kay,et al.  Subfertility before and after the Development of Rheumatoid Arthritis in Women , 1965, Annals of the rheumatic diseases.

[30]  E. Hargreaves,et al.  A Survey of Rheumatoid Arthritis in West Cornwall , 1958, Annals of the rheumatic diseases.